Organization (Hospital)
West Penn Allegheny Health System
ClinicalTrials.gov lists West Penn Allegheny Health System as lead sponsor of 19 trials. It has 11 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Allegheny Health Network, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers West Penn Allegheny Health System: 19 lead-sponsored trials and 0 legal-entity registrations.
Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.
Disease areas (123)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Breast Neoplasms | 12 |
| Pain | 5 |
| Anxiety Disorders | 4 |
| Hypertension, Pulmonary | 4 |
| Liver Neoplasms | 4 |
Showing 5 of 123 disease areas.
Trials by start year as sponsor or collaborator (16)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2023 | 4 |
| 2022 | 4 |
| 2019 | 3 |
| 2018 | 2 |
| 2017 | 1 |
| 2016 | 1 |
| 2015 | 2 |
| 2014 | 1 |
| 2012 | 3 |
Showing 10 of 16 years.
Recruitment duration, a model prediction: none of the 19 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Approved assets (11)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| Fluticasone, Budesonide, Beclomethasone | 1 |
| Budesonide, Fluticasone, Beclomethasone | 1 |
| Lidocaine Hydrochloride with Epinephrine | 1 |
| Budesonide, Beclomethasone, Fluticasone | 1 |
| Beclomethasone, Fluticasone, Budesonide | 1 |
Showing 5 of 11 approved assets.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 17% hit target (n=6) | 2 of 4 on time (n=4) |
Journals published in (161)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| JACC. Cardiovascular imaging | 7 |
| The Annals of thoracic surgery | 6 |
| Female pelvic medicine & reconstructive surgery | 5 |
| American journal of obstetrics and gynecology | 4 |
| Clinical orthopaedics and related research | 4 |
Showing 5 of 161 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 89 | 8 | 2025-12-23 |
Financing and grant events (9)
Shown in this order: most recent first.
| Date | Round type | Amount (USD) | Source |
|---|---|---|---|
| 2024-04-12 | NIH grant | 195,610 | Reporter |
| 2023-04-25 | NIH grant | 249,570 | Reporter |
| 2022-05-20 | NIH grant | 231,387 | Reporter |
| 2021-07-16 | NIH grant | 201,543 | Reporter |
| 2021-04-29 | NIH grant | 235,292 | Reporter |
Showing 5 of 9 events.
Organization relationships (83)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| UPMC Health System | Co sponsors trial with | 3 |
| The University of Texas System | Co sponsors trial with | 2 |
| University of California System | Co sponsors trial with | 2 |
| University of Pittsburgh | Co sponsors trial with | 2 |
| Indiana University | Co sponsors trial with | 2 |
Showing 5 of 83 relationships.
Latest dated events (199)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-07-31 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-27 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-06 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-06-30 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-06-18 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 199 events.
Biomarker capability evidence (31)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| CD19 | Trial collaborator | Named in trial inclusion criteria |
| GNRH1 | Trial collaborator | Named in trial inclusion criteria |
| LPL | Trial collaborator | Named in trial inclusion criteria |
| MS4A1 | Trial collaborator | Named in trial inclusion criteria |
| SLC30A8 | Trial collaborator | Named in trial inclusion criteria |
Showing 5 of 31 evidence rows.
Biomarkers this organization publishes on (193)
Shown in this order: most publications first.
Showing 5 of 193 biomarkers.
On Scientist.com
West Penn Allegheny Health System is listed as a research supplier in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, active development programs, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.
Work with Allegheny Singer Research Institute on Scientist.com
For prices, more details, or to contact Allegheny Singer Research Institute, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.